Expand your business
BOOK A STAND
At the heart of business and innovation in Biopharma
REGISTER NOW
Breakfast Session sponsored by bioLIVE: Accepting the Challenge
The second edition of CPhI North America is taking place on 24-26 April 2018 in Philadelphia, USA. The event will host numerous conferences, exhibitor showcases and special events.
On Wednesday, April 25, bioLIVE will host an invitation-only breakfast session on today’s pharmaceutical business landscape, and the need to connect biotechs, big pharma and service providers through the large molecule value chain. The most important meal of the day just got even more important!
Event Overview
bioLIVE is a new focused event with an exhibition and a live content stage, focusing on large molecule Biopharma and more specifically on manufacturing and processing. A unique platform connecting biotechs, big pharma and service providers across the whole value chain in large molecules.
bioLIVE runs adjacent to CPhI Worldwide, bringing small and large molecule worlds together, creating a platform where both industries can learn from each other.
The synergies and the exceptional audience of CPhI Worldwide, with 45,000 visitors over 3 days, will significantly benefit any company involved in the event.
There is great potential in bringing the bio community together – running at the same time as CPhI Worldwide. The launch of bioLIVE will help accelerate the development of the bio supply chain, improve knowledge exchange, and create a more collaborative bio/pharma environment.
Eric Langer, President and Managing Partner, BioPlan Associates
What to expect?
bioLIVE brings excellent science & technology, development and partnering opportunities through cutting edge onsite content and matchmaking.
Exhibit @ bioLIVE:
bioLIVE offers a unique opportunity for any company active in biopharma to put a spotlight on their offering in front of the entire pharma industry.
Who attends?
3000+ executives and senior level attendees responsible for sourcing, procurement, supply chain management, drug development, engineering, research and more from across the biopharma industry.
Who is involved
×